Delivery Order SPE2DB24D3014-SPE2DB25FKTKB
Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $41,480.93 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Rexulti 1 mg tablets (30-count units). This firm fixed-price, competitively awarded contract with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $9,608.75 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count packaging) on April 23, 2025, with completion scheduled for April 24, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical transaction under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order valued at $46,854.75 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Rexulti 2 mg tablets (30-count) valued at $34,056.64. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The pharmaceutical product will be performed at the...
- The Defense Logistics Agency awarded a $7,915.80 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rexulti 1 mg tablets (30-count). This firm fixed-price, non-set-aside contract is scheduled for completion by July 28, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $4,909.13. The award was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and does not utilize a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a $6,651.12 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Rexulti 0.5 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 28, 2025, and performance will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,077.96 on August 8, 2025, for the supply of Rexulti 1 mg tablets (30-count packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 11, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $7,259.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packaging). This firm fixed-price delivery order, issued on September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Rexulti 2 mg tablets (quantity: 30 units) with a ceiling value of $2,927.61. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....